Lotus Pharmaceutical Co Ltd
TWSE:1795

Watchlist Manager
Lotus Pharmaceutical Co Ltd Logo
Lotus Pharmaceutical Co Ltd
TWSE:1795
Watchlist
Price: 252.5 TWD 0.6% Market Closed
Market Cap: 67.1B TWD

Intrinsic Value

The intrinsic value of one Lotus Pharmaceutical Co Ltd stock under the Base Case scenario is 360.95 TWD. Compared to the current market price of 252.5 TWD, Lotus Pharmaceutical Co Ltd is Undervalued by 30%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

Intrinsic Value
360.95 TWD
Undervaluation 30%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Lotus Pharmaceutical Co Ltd

Intrinsic Value History
Dive into the past to invest in the future

Uncover deeper insights with the Valuation History. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start now and learn if your stock is truly undervalued or overvalued!

Start Valuation
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Lotus Pharmaceutical Co Ltd
Valuation History
HIDDEN
Show
Valuation History Unavailable

Historical valuation for Lotus Pharmaceutical Co Ltd cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%

Fundamental Analysis

Lotus Pharmaceutical Co Ltd
TWSE:1795
TW
Pharmaceuticals
Market Cap
67B TWD
IPO
Dec 13, 2004
TW
Pharmaceuticals
Market Cap
67B TWD
IPO
Dec 13, 2004
Price
NT$false
EPS
NT$false
Company Overview
Loading...
Business Segments
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about Lotus Pharmaceutical Co Ltd?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about Lotus Pharmaceutical Co Ltd
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Lotus Pharmaceutical Co Ltd

Current Assets 15.6B
Cash & Short-Term Investments 3.7B
Receivables 7.4B
Other Current Assets 4.5B
Non-Current Assets 21.6B
Long-Term Investments 3B
PP&E 3.7B
Intangibles 14.2B
Other Non-Current Assets 776.7m
Efficiency

Free Cash Flow Analysis
Lotus Pharmaceutical Co Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Lotus Pharmaceutical Co Ltd

Revenue
17.6B TWD
Cost of Revenue
-7.7B TWD
Gross Profit
9.9B TWD
Operating Expenses
-4.8B TWD
Operating Income
5.1B TWD
Other Expenses
-780.4m TWD
Net Income
4.3B TWD
Fundamental Scores

Profitability Score
Profitability Due Diligence

Lotus Pharmaceutical Co Ltd's profitability score is 62/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive 3-Year Average ROE
Positive Operating Income
Positive ROE
62/100
Profitability
Score

Lotus Pharmaceutical Co Ltd's profitability score is 62/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

Lotus Pharmaceutical Co Ltd's solvency score is 65/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Low D/E
Long-Term Solvency
65/100
Solvency
Score

Lotus Pharmaceutical Co Ltd's solvency score is 65/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
Lotus Pharmaceutical Co Ltd

Wall Street analysts forecast Lotus Pharmaceutical Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Lotus Pharmaceutical Co Ltd is 443.36 TWD with a low forecast of 342.39 TWD and a high forecast of 630 TWD.

Lowest
Price Target
342.39 TWD
36% Upside
Average
Price Target
443.36 TWD
76% Upside
Highest
Price Target
630 TWD
150% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for Lotus Pharmaceutical Co Ltd is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest
What is the Intrinsic Value of one Lotus Pharmaceutical Co Ltd stock?

The intrinsic value of one Lotus Pharmaceutical Co Ltd stock under the Base Case scenario is 360.95 TWD.

Is Lotus Pharmaceutical Co Ltd stock undervalued or overvalued?

Compared to the current market price of 252.5 TWD, Lotus Pharmaceutical Co Ltd is Undervalued by 30%.

Back to Top